Gamma-glutamyltransferase in fine-needle liver biopsies of subjects with chronic hepatitis C

Journal of Viral Hepatitis

Volumn 12, Issue 3, 2005, Pages 269-273

  Paolicchi, Aldo ^a   Marchi, S ^a   Petruccelli, S ^a   Ciancia, E ^b   Malvaldi, G ^a   Pompella, A ^a  

^a UNIVERSITY OF PISA   (Italy)

^b UNIVERSITY HOSPITAL OF PISA   (Italy)

Author keywords

Gamma glutamyltransferase; Hepatitis C; Inflammation; Oxidative stress

Indexed keywords

CYTOKINE; GAMMA GLUTAMYLTRANSFERASE; LEUKOTRIENE; NITRIC OXIDE;

ARTICLE; BILE DUCT; CLINICAL ARTICLE; ENZYME ACTIVITY; ENZYME HISTOCHEMISTRY; HEPATITIS C; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTRAHEPATIC BILE DUCT; LIVER BIOPSY; LIVER CELL; LIVER SINUSOID; NEEDLE BIOPSY; PRIORITY JOURNAL; PROGNOSIS;

BIOLOGICAL MARKERS; BIOPSY, NEEDLE; COHORT STUDIES; DISEASE PROGRESSION; FEMALE; GAMMA-GLUTAMYLTRANSFERASE; HEPATITIS C, CHRONIC; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; OXIDATIVE STRESS; PROGNOSIS; SENSITIVITY AND SPECIFICITY;

EID: 18344369008     PISSN: 13520504     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2893.2005.00579.x     Document Type: Article

References (20)

1. 2a in patients with chronic hepatitis C infected by virus genotype 3a and exibiting a low ggt/ALT ratio. Dig Dis Sci 1996; 41: 1256-1264.
2. Chayama K, Tsubota A, Kobayashi M et al. Pretreatment virus load and multiple aminoacid substitutions in the interferon sensitivity-determining region predict the outcome of interferon treatment in patients with chronic genotype 1b hepatitis C virus infection. Hepatology 1997; 25: 745-749.
3. Kurosaki M, Enomoto N, Murakami T et al. Analysis of genotypes and amino acid residues 2209-to 2248 of the NS5A region of hepatitis C virus in relation to the response to interferon-β therapy. Hepatology 1997; 25: 750-753.
4. Mihm S, Monazahian M, Grethe S, Fechner C, Ramadori G, Thomssen R. Ratio of Serum γ-GT/ALT rather than ISDR variability is predictive for initial virological response to IFN-a in chronic HCV infection. J Med Virol 1999; 58: 227-234.
5. Testa R, Giannini E, Picciotto A et al. Probability of nonresponse during interferon therapy in patients with chronic hepatitis C. Hepatogastroenterology 1999; 46: 1928-1936.
6. Hwang SJ, Luo JC, Lai CR et al. Clinical, virological and pathological significance of elevated serum gamma-glutamyltranspeptidase in patients with chronic hepatitis C. Zhonghua Yi Xue Za Zhi (Taipei) 2000; 63: 527-535.
7. Kiso S, Kawata S, Imai Y et al. Efficacy of ursodesoxycholic acid therapy in chronic viral hepatitis C with high serum gamma-glutamyltranspeptidase levels. J Gastroenterol 1996; 31: 75-80.
8. Benvegnu L, Chemello L, Noventa F, Fattovich G, Pontisso P, Alberti A. Retrospective analysis of the effect of interferon therapy on the clinical outcome of patients with liver cirrhosis. Cancer 1998; 83: 901-909.
9. Hanigan MH, Frierson HF, Jr. Immunohistochemical detection of gamma-glutamyl transpeptidase in normal human tissue. J Histochem Cytochem 1996; 44: 1101-1108.
10. Khalaf MR, Hayhoe FGJ. Cytochemistry of γ-glutamyltransferase in haemic cells and malignancies. Histochem J 1987; 19: 385-395.
11. Satoh T, Takenaga M, Kitagawa H, Itoh S. Microassay of gamma-glutamyl transpeptidase in needle biopsies of human liver. Res Commun Chem Pathol Pharmacol 1980; 30: 151-161.
12. Huseby NE. Multiple forms of serum gamma-glutamyltransferase. Association of the enzyme with lipoproteins. Clin Chim Acta 1982; 124: 103-112.
13. Huseby NE. Separation and characterization of human gamma- glutamyltransferases. Clin Chim Acta 1981; 111: 39-45.
14. Huseby NE, Ingebretsen OC. The level of γ-glutamyltransferase in serum, effect of carbohydrate heterogeneity on clearance rate. Scand J Clin Lab Invest 1993; 53(Suppl. 215): 93-100.
15. Meister A. Metabolism and transport of glutathione and other γ-glutamyl compounds. In: Larsson A, Orrenius S, Holmgren A, Mannervik B, eds. Functions of Glutathione: Biochemical, Toxicological and Clinical Aspects. New York: Raven Press, 1983: 1-22.
16. Orning L, Hammarstrom S. Kinetics of the conversion of leukotriene C by gamma-glutamyl transpeptidase. Biochem Biophys Res Commun 1982; 106: 1304-1309.
17. Laouar A, Wietzerbin J, Bauvois B. Protease-catalyzed conversion of insulin-like growth factor-1 and interleukin-6 into high-molecular-mass species through the sequential action of hematopoietic surface-associated cathepsin G and gamma-glutamyl transpeptidase-related activities. Eur J Biochem 1994; 223: 617-624.
18. Hogg N, Singh RJ, Konorev E, Joseph J, Kalyanaraman B. S-nitrosoglutathione as a substrate for gamma-glutamyl transpeptidase. Biochem J 1997; 323: 477-481.
19. Stark AA, Zeiger E, Pagano DA. Glutathione metabolism by gamma glutamyltranspeptidase leads to lipid peroxidation: characterization of the system and relevance to hepatocarcinogenesis. Cardnogenesis 1993; 14: 183-189.
20. Taliani G, Badolato MC, Nigro G et al. Serum concentration of γ-GT is a surrogate marker of hepatic TNF-α mRNA expression in chronic hepatitis C. Clin Immunol 2002; 105: 279-285.